Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health : names Dr. Joneigh S. Khaldun as Vice President and Chief Health Equity Officer

10/15/2021 EST

WOONSOCKET, R.I. - CVS Health (NYSE: CVS) today announced that Joneigh Khaldun, M.D., MPH, FACEP has joined the company as Vice President and Chief Health Equity Officer. She will report to Kyu Rhee, M.D., MPP, Senior Vice President and Aetna Chief Medical Officer.

Dr. Khaldun will lead the strategy to advance health equity for patients, members, providers, customers, and communities served across all lines of the CVS Health business. She and her team will focus on culturally competent care delivery, ensuring it is fully integrated into the design and development of clinical and population health programs, products, services, interactions and communications. She will also work collaboratively with the broader health care system to advance health equity and better support underserved communities.

"As a health care innovation company committed to health equity and breaking down barriers that perpetuate health care disparities, Dr. Khaldun joins our team as Chief Health Equity Officer at a critically important time," said Rhee. "Her expertise in creating solutions to help improve health outcomes will help us continue addressing health inequities for the customers and communities we serve."

Prior to joining CVS Health, Dr. Khaldun served as the Chief Medical Executive for the State of Michigan and Chief Deputy Director for Health in the Michigan Department of Health and Human Services, where she was responsible for public health and aging programs, Medicaid and behavioral health. She led Michigan's COVID-19 response and is credited for Michigan's early identification of and strategy to address disparities in COVID-19 outcomes. In 2021, she was named by President Biden to the COVID-19 Health Equity Task Force.

Previously, Dr. Khaldun held several positions that leveraged her expertise in improving, expanding and modernizing the delivery of community health services, including Director and Health Officer for the Detroit Health Department and Chief Medical Officer of the Baltimore City Health Department. She was also Director of the Center for Injury Prevention and Control at George Washington University, Founder and Director of the Fellowship in Health Policy in the University of Maryland Department of Emergency Medicine, and Fellow in the Obama-Biden administration's Office of Health Reform in the U.S. Department of Health and Human Services.

Dr. Khaldun obtained her undergraduate degree from the University of Michigan, medical degree from the University of Pennsylvania, MPH in Health Policy from George Washington University, and completed residency in emergency medicine at SUNY Downstate Medical Center/Kings County Hospital in Brooklyn, NY. She practices emergency medicine part-time at Henry Ford Hospital in Detroit.

She currently serves on the National Advisory Board for the Institute for Healthcare Policy and Innovation at the University of Michigan, the Board of Directors of Big Brothers Big Sisters of Metropolitan Detroit, and on the Health and Medicine Committee of the National Academies of Science, Engineering and Medicine. She is an Adjunct Professor in the Department of Health Policy and Management in the University of Michigan School of Public Health.

About CVS Health

CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and our nearly 300,000 dedicated colleagues - including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health - whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system - and their personal health care - by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.

Media contact

Ethan Slavin


CVS Health Corporation published this content on 15 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 October 2021 12:41:05 UTC.

ę Publicnow 2021
11:31aMorgan Stanley Adjusts CVS Health PT to $115 From $114, Maintains Overweight Rating
11:09aCVS Health Reminds Americans to Get Their Flu Shot During National Influenza Vaccinatio..
12/03NORTH AMERICAN MORNING BRIEFING : Oil Rises, Stock Futures Waver as Markets Cap Volatile W..
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
12/02CVS HEALTH : named to 2021 Dow Jones Sustainability Index
12/01CVS Health to Invest $9.2 Million in Affordable Housing in Washington, D.C.
12/01WALL STREET STOCK EXCHANGE : The Fed takes a new stance
12/01ANALYST RECOMMENDATIONS : American Water, CVS, D.R. Horton, Ferrari, Marvell Technology.....
12/01Seaport Global Starts CVS Health at Buy With $110 Price Target
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 289 B - -
Net income 2021 8 070 M - -
Net Debt 2021 48 268 M - -
P/E ratio 2021 14,6x
Yield 2021 2,20%
Capitalization 120 B 120 B -
EV / Sales 2021 0,58x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,7%
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 90,87 $
Average target price 105,60 $
Spread / Average Target 16,2%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors